Placebo caplet of DLBS2411

DRUG3 trials

Sponsors

Dexa Medica Group

Conditions

Functional DyspepsiaGastroesophageal Reflux Disease (GERD)Non-Bleeding Peptic Ulcers

Phase 3

DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers

TerminatedNCT02262169

Dexa Medica GroupNon-Bleeding Peptic Ulcers

Start: 2014-10-31End: 2019-03-31Updated: 2019-07-09

Efficacy and Safety of DLBS2411 in the Management of GERD

TerminatedNCT03367195

Dexa Medica GroupGastroesophageal Reflux Disease (GERD)

Start: 2018-08-16End: 2020-09-09Updated: 2021-01-07

DLBS2411 Treatment For Functional Dyspepsia

CompletedNCT05248802

Dexa Medica GroupFunctional Dyspepsia

Start: 2022-12-09End: 2025-10-01Updated: 2026-02-17